What is Advanced Health Intelligence Sloan Ratio %?
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
When sloan ratio (-53.79)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.
As of Sep. 2023, Advanced Health Intelligence has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
Advanced Health Intelligence Sloan Ratio % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Advanced Health Intelligence's Sloan Ratio %
For the Software - Application subindustry, Advanced Health Intelligence's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Health Intelligence's Sloan Ratio % Distribution in the Software Industry
For the Software industry and Technology sector, Advanced Health Intelligence's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Advanced Health Intelligence's Sloan Ratio % falls into.
Advanced Health Intelligence Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Advanced Health Intelligence's Net Income for the trailing twelve months (TTM) ended in Sep. 2023 was 0 (Dec. 2022 ) + 0 (Mar. 2023 ) + 0 (Jun. 2023 ) + 0 (Sep. 2023 ) = A$0.00 Mil.
Advanced Health Intelligence's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2023 was 0 (Dec. 2022 ) + -0.815 (Mar. 2023 ) + -2.662 (Jun. 2023 ) + -3.014 (Sep. 2023 ) = A$-6.49 Mil.
Advanced Health Intelligence's Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2023 was 0 (Dec. 2022 ) + -0.003 (Mar. 2023 ) + 0.722 (Jun. 2023 ) + -0.095 (Sep. 2023 ) = A$0.62 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Health Intelligence (ASX:AHI) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Sep. 2023, Advanced Health Intelligence has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
Advanced Health Intelligence Sloan Ratio % Related Terms
Thank you for viewing the detailed overview of Advanced Health Intelligence's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.
Advanced Health Intelligence (ASX:AHI) Business Description
Advanced Health Intelligence Ltd (AHI) is engaged in developing and delivering user-friendly biometric scans to render vital signs and health risk estimates to a smartphone. By leveraging the smartphone with purpose-built computer vision, machine learning models, and patented algorithms, AHI provides a private and secure way for individuals to perform biometric health-risk assessment and stratification. AHI's technology delivers simple-to-use, scalable, and cost-effective means to enable individuals to check, track and act towards better health outcomes. The combination of the patented and proprietary BodyScan dimensioning and composition capabilities and, FaceScan to return vital signs enables a unique health assessment capability made accessible anytime, anywhere through the smartphone.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:AHI has been successfully added to your 